These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 25838090

  • 41. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
    Yamanaka K, Shah SA, Sakaida H, Yamagiwa A, Masuda S, Mizutani H, Takeuchi K.
    Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
    [Abstract] [Full Text] [Related]

  • 42. [Prevalence of allergic rhinitis among asthmatic patients in two different seasons].
    Kamijo A, Soma T, Uchida Y, Araki R, Kobayashi T, Inoue H, Komiyama K, Tokuyama K, Kase Y, Nagata M.
    Arerugi; 2013 Dec; 62(12):1642-50. PubMed ID: 24608653
    [Abstract] [Full Text] [Related]

  • 43. Release of IL-4 and IL-5 from human peripheral blood mononuclear cells co-cultured with Japanese cedar pollen antigen in vitro.
    Kimura H, Shibata Y, Minakami H, Hashizume S, Oba H, Sakaguchi M, Otsuki K, Kato M.
    Cell Biol Int; 2001 Dec; 25(8):841-4. PubMed ID: 11482911
    [Abstract] [Full Text] [Related]

  • 44. [Seasonal changes of laboratory data in patients with Japanese cedar pollinosis].
    Fujiwara H, Masuda M, Kubo N, Okochi H, Shimoshikiryo K, Okamoto H, Hara K, Ogawa N, Takahashi H.
    Rinsho Byori; 1997 May; 45(5):487-92. PubMed ID: 9170978
    [Abstract] [Full Text] [Related]

  • 45. Prevalence and risk factors of allergic rhinitis and cedar pollinosis among Japanese men.
    Sakurai Y, Nakamura K, Teruya K, Shimada N, Umeda T, Tanaka H, Yoshizawa N.
    Prev Med; 1998 May; 27(4):617-22. PubMed ID: 9672957
    [Abstract] [Full Text] [Related]

  • 46. Orally exhaled nitric oxide in patients with seasonal allergic rhinitis during natural pollen season.
    Ciebiada M, Cichocki P, Kasztalska K, Majewski S, Gorska-Ciebiada M, Gorski P.
    Am J Rhinol Allergy; 2012 May; 26(1):e32-6. PubMed ID: 22391078
    [Abstract] [Full Text] [Related]

  • 47. Analysis of factors associated with cedar pollen sensitization and development of pollinosis in a young Japanese adult population.
    Nakamura S, Tsunoda S, Sakaida H, Masuda S, Said AS, Takeuchi K.
    Allergol Int; 2019 Jan; 68(1):39-45. PubMed ID: 29908674
    [Abstract] [Full Text] [Related]

  • 48. Association between first airborne cedar pollen level peak and pollinosis symptom onset: a web-based survey.
    Bando H, Sugiura H, Ohkusa Y, Akahane M, Sano T, Jojima N, Okabe N, Imamura T.
    Int J Environ Health Res; 2015 Jan; 25(1):104-13. PubMed ID: 24720339
    [Abstract] [Full Text] [Related]

  • 49. Cedar and cypress pollinosis and allergic rhinitis: quality of life effects of early intervention with leukotriene receptor antagonists.
    Sasaki K, Okamoto Y, Yonekura S, Okawa T, Horiguchi S, Chazono H, Hisamitsu M, Sakurai D, Hanazawa T, Okubo K.
    Int Arch Allergy Immunol; 2009 Jan; 149(4):350-8. PubMed ID: 19295239
    [Abstract] [Full Text] [Related]

  • 50. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Effect of posterior nasal neurectomy combined with the inferior turbinate surgery for Japanese cedar pollinosis].
    Kamijo A, Kuroda Y, Hatsushika K, Nakajima M, Yamamoto T, Moriyama M, Okamoto A, Kase Y, Masuyama K.
    Arerugi; 2013 May; 62(5):560-5. PubMed ID: 23760201
    [Abstract] [Full Text] [Related]

  • 53. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.
    Ogino S, Nagakura T, Okubo K, Sato N, Takahashi M, Ishikawa T.
    Int Arch Allergy Immunol; 2009 May; 149(3):239-45. PubMed ID: 19218816
    [Abstract] [Full Text] [Related]

  • 54. Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development.
    Xiao JZ, Kondo S, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Enomoto T.
    Int Arch Allergy Immunol; 2007 May; 144(2):123-7. PubMed ID: 17536220
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Delay of onset of symptoms of Japanese cedar pollinosis by treatment with a leukotriene receptor antagonist.
    Gotoh M, Suzuki H, Okubo K.
    Allergol Int; 2011 Dec; 60(4):483-9. PubMed ID: 21778814
    [Abstract] [Full Text] [Related]

  • 57. Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting.
    Yonekura S, Okamoto Y, Okubo K, Okawa T, Gotoh M, Suzuki H, Kakuma T, Horiguchi S, Hanazawa T, Konno A, Okuda M.
    J Investig Allergol Clin Immunol; 2009 Dec; 19(3):195-203. PubMed ID: 19610262
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.